252 related articles for article (PubMed ID: 35358035)
1. Challenges to Adolescent HPV Vaccination and Implementation of Evidence-Based Interventions to Promote Vaccine Uptake During the COVID-19 Pandemic: "HPV Is Probably Not at the Top of Our List".
Ryan G; Gilbert PA; Ashida S; Charlton ME; Scherer A; Askelson NM
Prev Chronic Dis; 2022 Mar; 19():E15. PubMed ID: 35358035
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel.
Lavie M; Lavie I; Laskov I; Cohen A; Grisaru D; Grisaru-Soen G; Michaan N
J Low Genit Tract Dis; 2023 Apr; 27(2):168-172. PubMed ID: 36815631
[TBL] [Abstract][Full Text] [Related]
3. Understanding Clinic and Community Member Experiences with Implementation of Evidence-Based Strategies for HPV Vaccination in Safety-Net Primary Care Settings.
Tsui J; Shin M; Sloan K; Martinez B; Palinkas LA; Baezconde-Garbanati L; Cantor JC; Hudson SV; Crabtree BF
Prev Sci; 2024 Apr; 25(Suppl 1):147-162. PubMed ID: 37368117
[TBL] [Abstract][Full Text] [Related]
4. Understanding Implementation of Evidence-Based Interventions to Address Human Papillomavirus Vaccination: Qualitative Perspectives of Middle Managers.
Ryan GW; Charlton ME; Scherer AM; Ashida S; Gilbert PA; Daly E; Askelson NM
Clin Pediatr (Phila); 2023 Oct; 62(10):1193-1200. PubMed ID: 36762821
[TBL] [Abstract][Full Text] [Related]
5. Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
Olusanya OA; White B; Malik F; Hester KA; Davis RL; Bednarczyk RA; Shaban-Nejad A
PLoS One; 2022; 17(11):e0277748. PubMed ID: 36399477
[TBL] [Abstract][Full Text] [Related]
6. Getting Human Papillomavirus Vaccination Back on Track: A National Survey.
Kahn BZ; Huang Q; Thompson P; Gilkey MB; Alton Dailey S; Brewer NT
J Adolesc Health; 2023 Jun; 72(6):950-957. PubMed ID: 36922312
[TBL] [Abstract][Full Text] [Related]
7. Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California.
Chao CR; Xu L; Cannizzaro N; Bronstein D; Choi Y; Riewerts R; Mittman B; Zimmerman RK; Gilkey M; Glenn B; Shen E; Hsu C; Hahn EE
Vaccine; 2022 Nov; 40(46):6575-6580. PubMed ID: 36243591
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 pandemic and vaccine perceptions on HPV vaccine hesitancy.
Schelbar N; Ward CN; Phillips E; Herr MJ; Acevedo S; Conner H; Greiner A; Corriveau E
Am J Otolaryngol; 2024; 45(2):104172. PubMed ID: 38103489
[TBL] [Abstract][Full Text] [Related]
9. Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics.
Barnard JG; Marsh R; Anderson-Mellies A; Williams JL; Fisher MP; Cockburn MG; Dempsey AF; Cataldi JR
Vaccine; 2022 Aug; 40(33):4835-4844. PubMed ID: 35792022
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 on HPV Vaccination Rates in New York City and Long Island.
Bower M; Kothari U; Akerman M; Krilov LR; Fiorito TM
Pediatr Infect Dis J; 2024 Jan; 43(1):84-87. PubMed ID: 37963272
[TBL] [Abstract][Full Text] [Related]
11. Stakeholders' perspectives on barriers to and facilitators of school-based HPV vaccination in the context of COVID-19 pandemic-related disruption: a qualitative mixed methods study.
Khan A; Abonyi S; Neudorf C; Galea S; Ahmed S
Int J Qual Stud Health Well-being; 2024 Dec; 19(1):2295879. PubMed ID: 38118074
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic.
Ejezie CL; Savas LS; Durand C; Shegog R; Cuccaro P
JNCI Cancer Spectr; 2023 Aug; 7(5):. PubMed ID: 37651597
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and Barriers to the Implementation of the HPV VACs (Vaccinate Adolescents Against Cancers) Program: A Consolidated Framework for Implementation Research Analysis.
Escoffery C; Riehman K; Watson L; Priess AS; Borne MF; Halpin SN; Rhiness C; Wiggins E; Kegler MC
Prev Chronic Dis; 2019 Jul; 16():E85. PubMed ID: 31274411
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States.
Abouelella DK; Canick JE; Barnes JM; Rohde RL; Watts TL; Adjei Boakye E; Osazuwa-Peters N
Hum Vaccin Immunother; 2022 Dec; 18(7):2148825. PubMed ID: 36484115
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Based Practice Model to Increase Human Papillomavirus Vaccine Uptake: A Stepwise Approach.
Beck A; Bianchi A; Showalter D
Nurs Womens Health; 2021 Dec; 25(6):430-436. PubMed ID: 34634248
[TBL] [Abstract][Full Text] [Related]
16. Exploring HPV vaccination policy and payer strategies for opportunities to improve uptake in safety-net settings.
Sloan K; Shin M; Palinkas LA; Hudson SV; Crabtree BF; Cantor JC; Tsui J
Front Public Health; 2023; 11():1099552. PubMed ID: 37213634
[TBL] [Abstract][Full Text] [Related]
17. Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial.
Calo WA; Shah PD; Fogel BN; Ruffin Iv MT; Moss JL; Hausman BL; Segel JE; Francis E; Schaefer E; Bufalini CM; Johnston N; Hogentogler E; Kraschnewski JL
Contemp Clin Trials; 2023 Aug; 131():107266. PubMed ID: 37301468
[TBL] [Abstract][Full Text] [Related]
18. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
[TBL] [Abstract][Full Text] [Related]
19. Uptake of HPV vaccination among boys after the introduction of gender-neutral HPV vaccination in Germany before and during the COVID-19 pandemic.
Wähner C; Hübner J; Meisel D; Schelling J; Zingel R; Mihm S; Wölle R; Reuschenbach M
Infection; 2023 Oct; 51(5):1293-1304. PubMed ID: 36763286
[TBL] [Abstract][Full Text] [Related]
20. Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives.
Yared N; Malone M; Welo E; Mohammed I; Groene E; Flory M; Basta NE; Horvath KJ; Kulasingam S
Cancer Causes Control; 2021 Oct; 32(10):1107-1116. PubMed ID: 34247291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
